GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Medical & HealthCare Group Ltd (HKSE:00383) » Definitions » Cash Conversion Cycle

China Medical & HealthCare Group (HKSE:00383) Cash Conversion Cycle : 37.64 (As of Dec. 2023)


View and export this data going back to 1991. Start your Free Trial

What is China Medical & HealthCare Group Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

China Medical & HealthCare Group's Days Sales Outstanding for the six months ended in Dec. 2023 was 21.25.
China Medical & HealthCare Group's Days Inventory for the six months ended in Dec. 2023 was 81.75.
China Medical & HealthCare Group's Days Payable for the six months ended in Dec. 2023 was 65.36.
Therefore, China Medical & HealthCare Group's Cash Conversion Cycle (CCC) for the six months ended in Dec. 2023 was 37.64.


China Medical & HealthCare Group Cash Conversion Cycle Historical Data

The historical data trend for China Medical & HealthCare Group's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Medical & HealthCare Group Cash Conversion Cycle Chart

China Medical & HealthCare Group Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.53 42.10 24.95 38.81 51.15

China Medical & HealthCare Group Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.85 36.65 67.22 49.86 37.64

Competitive Comparison of China Medical & HealthCare Group's Cash Conversion Cycle

For the Medical Care Facilities subindustry, China Medical & HealthCare Group's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Medical & HealthCare Group's Cash Conversion Cycle Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, China Medical & HealthCare Group's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where China Medical & HealthCare Group's Cash Conversion Cycle falls into.



China Medical & HealthCare Group Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

China Medical & HealthCare Group's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=18.1+88.19-55.14
=51.15

China Medical & HealthCare Group's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=21.25+81.75-65.36
=37.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Medical & HealthCare Group  (HKSE:00383) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


China Medical & HealthCare Group Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of China Medical & HealthCare Group's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


China Medical & HealthCare Group (HKSE:00383) Business Description

Traded in Other Exchanges
Address
333 Lockhart Road, 47th Floor, United Asia Finance Centre, Wanchai, Hong Kong, HKG
China Medical & HealthCare Group Ltd is a healthcare company operating hospitals. Its main focus is on the investment, management, and operations of healthcare and hospital businesses, eldercare businesses, trading of medical equipment and related supplies, property investment and development, securities trading and investments, provision of financial services, and strategic investment. It operates through the following business segments: Healthcare, Eldercare; Property development; Property investment; Financial services; and Securities trading and investments. The firm generates the majority of revenue from the Healthcare segment that is engaged in the operations of hospitals in the PRC.

China Medical & HealthCare Group (HKSE:00383) Headlines

No Headlines